10x Genomics, Inc. TXG Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingActivitiesCashFlowStatement.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is 10x Genomics, Inc.'s other working capital?
- 10x Genomics, Inc. (TXG) reported other working capital of -$193K in Q1 2026.
- How has 10x Genomics, Inc.'s other working capital changed year-over-year?
- 10x Genomics, Inc.'s other working capital increased by 66.4% year-over-year, from -$575K to -$193K.
- What is the long-term trend for 10x Genomics, Inc.'s other working capital?
- Over 3 years (2021 to 2025), 10x Genomics, Inc.'s other working capital has grown at a 181.0% compound annual growth rate (CAGR), from $79K to -$1.75M.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.